Clinical Trial Update: Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial from Fudan University evaluating the combination of rimegepant with a PD-1 inhibitor for colorectal cancer with liver metastases; recruitment ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• PD-1 inhibitor
• Rimegepant (rimegepant)

Snippet

Sponsor: Fudan University | Conditions: Colon Cancer | Phase 2 | Status: NOT_YET_RECRUITING